levodopa has been researched along with Chemical Dependence in 45 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (33.33) | 18.7374 |
1990's | 7 (15.56) | 18.2507 |
2000's | 13 (28.89) | 29.6817 |
2010's | 10 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bichon, A; Broussolle, E; Carnicella, S; Castrioto, A; Delpont, B; Fraix, V; Kistner, A; Klinger, H; Krack, P; Lhommée, E; Lüscher, C; Pélissier, P; Pollak, P; Quesada, JL; Schmitt, E; Thobois, S | 1 |
Bastiampillai, T; Chuck, W; Dhillon, R; Okungu, A; Tibrewal, P | 1 |
Kobayashi, S; Matsuda, N; Ugawa, Y | 1 |
Januário, C; Morgadinho, A; Reis Carneiro, D; Sousa, M | 1 |
Arnulf, I; Brion, A; Karroum, E; Konofal, E; Leu-Semenescu, S | 1 |
Grabowski, J; Herin, DV; Rush, CR | 1 |
San Luciano, M; Saunders-Pullman, R | 1 |
Pandya, M; Zaharna, M | 1 |
Ambermoon, P; Carter, A; Dissanayaka, NN; Hall, WD; O'Sullivan, JD | 1 |
Dagher, A | 1 |
Ambermoon, P; Carter, A; Dissanayaka, N; Hall, W; O'Sullivan, J | 1 |
Girault, JA | 1 |
Gertz, HJ; Hermann, W; Müller, U; Reuter, M | 1 |
Steiner, I; Wirguin, I | 1 |
Al-Din, A; Lily, O | 1 |
Bearn, J; Evans, A; Kelleher, M; Lees, A; Turner, K | 1 |
Borek, LL; Friedman, JH | 1 |
Appel, S; Brooks, DJ; Doder, M; Evans, AH; Lawrence, AD; Lees, AJ; Pavese, N; Piccini, P; Tai, YF | 1 |
Cardoso, FE; Kummer, A; Maia, DP; Salgado, JV; Teixeira, AL | 1 |
Giladi, N; Merims, D | 1 |
Bria, P; Dario, T; Frustaci, A; Janiri, L; Martinotti, G; Pozzi, G; Reina, D | 1 |
Isaksson, B | 1 |
Priebe, S | 1 |
Matthews, D; Mawdsley, C; Pentland, B | 1 |
Calne, DB; Hashimoto, S; Hayward, M; Markey, CJ; Markey, SP; Richmond, J; Shinotoh, H; Snow, BJ; Uitti, RJ; Vingerhoets, FJ | 1 |
Ellis, KL; Speed, J | 1 |
Sunohara, N | 1 |
Mahowald, MW; Schenck, CH | 1 |
Sanchez-Ramos, J | 1 |
Halvorsen, KA; Martensen-Larsen, O | 1 |
Williamson, J | 1 |
Klawans, HL; Margolin, DI | 1 |
Heninger, GR; Kleber, HD; Kosten, TR; McDougle, CJ; Palumbo, JM; Price, LH | 1 |
Huppert, D; Soyka, M | 1 |
Abbott, RJ; Millac, PA; Ray-Chaudhuri, K | 1 |
Angrist, B; Wolfsohn, R | 1 |
Shannon, J; Tennant, F | 1 |
Harvey, NS | 1 |
De Cuypere, G; Jannes, C; Remouchamps, A; Tack, E | 1 |
Calne, DB; Hurwitz, TA; Waterman, K | 1 |
Berman, ML; Tennant, F | 1 |
Flemenbaum, A; Rosen, H; Slater, VL | 1 |
Ballard, PA; Langston, JW; Tetrud, JW | 1 |
Nausieda, PA | 1 |
AuAutret, A | 1 |
8 review(s) available for levodopa and Chemical Dependence
Article | Year |
---|---|
Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies.
Topics: Animals; Behavior Therapy; Benzhydryl Compounds; Bupropion; Central Nervous System Stimulants; Clinical Trials as Topic; Cognition; Dextroamphetamine; Humans; Levodopa; Methylphenidate; Modafinil; Substance-Related Disorders | 2010 |
Substance abuse and movement disorders.
Topics: Alcoholism; Animals; Apomorphine; Humans; Levodopa; Movement Disorders; Parkinson Disease; Substance Withdrawal Syndrome; Substance-Related Disorders | 2009 |
Impulse control disorders in patients with Parkinson's disease receiving dopamine replacement therapy: evidence and implications for the addictions field.
Topics: Adult; Aged; Behavior, Addictive; Binge-Eating Disorder; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Epidemiologic Factors; Epidemiologic Methods; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Sexual Dysfunctions, Psychological; Substance-Related Disorders | 2011 |
Signaling in striatal neurons: the phosphoproteins of reward, addiction, and dyskinesia.
Topics: Antiparkinson Agents; Basal Ganglia; Corpus Striatum; Cyclic AMP-Dependent Protein Kinases; Dopamine; Dopamine and cAMP-Regulated Phosphoprotein 32; Humans; Levodopa; MAP Kinase Signaling System; Models, Neurological; Movement Disorders; Nerve Tissue Proteins; Neuronal Plasticity; Neurons; Phosphoproteins; Phosphorylation; Protein Processing, Post-Translational; Receptors, Glutamate; Reward; Substance-Related Disorders | 2012 |
Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease.
Topics: Antiparkinson Agents; Behavioral Symptoms; Dopamine; Gambling; Humans; Levodopa; Parkinson Disease; Substance-Related Disorders | 2008 |
Requirements and appropriate intakes of electrolytes.
Topics: Aged; Cathartics; Diet; Diuretics; Electrolytes; Glycyrrhiza; Humans; Hypokalemia; Levodopa; Nutritional Requirements; Plants, Medicinal; Potassium; Sodium; Substance-Related Disorders; Sweat; Water-Electrolyte Balance | 1983 |
[Toxic and adverse neurological effects of anti-parkinsonian drugs].
Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Cholinergic Antagonists; Dopamine Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Neuroleptic Malignant Syndrome; Psychoses, Substance-Induced; Substance-Related Disorders | 1999 |
Psychiatric disorders in parkinsonism: 2. Organic cerebral states and drug reactions.
Topics: Amantadine; Antiparkinson Agents; Atrophy; Brain; Bromocriptine; Cognition; Dementia; Dreams; Drug Interactions; Ergolines; Humans; Levodopa; Libido; Memory; Parasympatholytics; Parkinson Disease; Receptors, Dopamine; Sexual Behavior; Substance-Related Disorders; Visual Perception | 1986 |
37 other study(ies) available for levodopa and Chemical Dependence
Article | Year |
---|---|
Psychostimulant effect of dopaminergic treatment and addictions in Parkinson's disease.
Topics: Aged; Behavior, Addictive; Central Nervous System Stimulants; Depressive Disorder; Dopamine Agents; Dyskinesia, Drug-Induced; Euphoria; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Substance-Related Disorders | 2017 |
Conversion Parkinson's disease with levodopa abuse and psychosis.
Topics: Adult; Antiparkinson Agents; Conversion Disorder; Female; Humans; Levodopa; Parkinson Disease; Psychotic Disorders; Substance-Related Disorders | 2017 |
[Devotion to painting in a Parkinson's disease patient].
Topics: Aged; Disease Progression; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Levodopa; Male; Paintings; Parkinson Disease; Substance-Related Disorders | 2018 |
Dopamine dysregulation syndrome induced by proxy.
Topics: Aged; Carbidopa; Disruptive, Impulse Control, and Conduct Disorders; Drug Combinations; Female; Humans; Levodopa; Parkinson Disease; Substance-Related Disorders; Syndrome | 2019 |
Dopamine dysregulation syndrome in a patient with restless legs syndrome.
Topics: Aged; Dopamine Agents; Humans; Levodopa; Male; Restless Legs Syndrome; Substance-Related Disorders | 2009 |
Levodopa addiction and factitious disorder in a patient with idiopathic Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Factitious Disorders; Female; Humans; Levodopa; Parkinson Disease; Substance-Related Disorders | 2010 |
Addiction as aberrant learning-evidence from Parkinson's disease.
Topics: Antiparkinson Agents; Dopamine Agents; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine; Reinforcement, Psychology; Substance-Related Disorders; Syndrome | 2012 |
Stimulating debate in the field of addiction.
Topics: Antiparkinson Agents; Dopamine Agents; Humans; Levodopa; Parkinson Disease; Substance-Related Disorders | 2012 |
[Levodopa dependency in Parkinson's disease: case report and review].
Topics: Adult; Antiparkinson Agents; Combined Modality Therapy; Diagnosis, Differential; Dose-Response Relationship, Drug; Humans; Levodopa; Limbic System; Male; Mental Status Schedule; Mesencephalon; Neurologic Examination; Parkinson Disease; Patient Care Team; Psychoses, Substance-Induced; Receptors, Dopamine; Substance-Related Disorders | 2002 |
Levodopa addiction in non-parkinsonian patients.
Topics: Adult; Antiparkinson Agents; Dopamine Agents; Female; Humans; Levodopa; Parkinson Disease; Substance-Related Disorders | 2003 |
Case study: cerebrovascular parkinsonism with levodopa addiction.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Cerebrovascular Disorders; Female; Humans; Levodopa; Parkinson Disease; Parkinsonian Disorders; Substance Withdrawal Syndrome; Substance-Related Disorders | 2004 |
Recognition of a dopamine replacement therapy dependence syndrome in Parkinson's disease: a pilot study.
Topics: Adult; Aged; Comorbidity; Dopamine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pilot Projects; Statistics, Nonparametric; Substance-Related Disorders | 2004 |
Levodopa addiction in idiopathic Parkinson disease.
Topics: Aged; Bipolar Disorder; Dopamine Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced; Quadriplegia; Spinal Cord Diseases; Substance-Related Disorders | 2005 |
Compulsive drug use linked to sensitized ventral striatal dopamine transmission.
Topics: Aged; Brain Mapping; Dopamine; Dopamine Agents; Dopamine Antagonists; Exploratory Behavior; Female; Humans; Levodopa; Male; Middle Aged; Neostriatum; Positron-Emission Tomography; Psychological Tests; Raclopride; Receptors, Dopamine D2; Receptors, Dopamine D3; Substance-Related Disorders; Synaptic Transmission | 2006 |
Dopamine dysregulation syndrome in Parkinson's disease: case report.
Topics: Aged; Antiparkinson Agents; Dopamine; Humans; Levodopa; Male; Mood Disorders; Parkinson Disease; Substance-Related Disorders; Syndrome | 2006 |
The assessment of post-detoxification anhedonia: influence of clinical and psychosocial variables.
Topics: Adolescent; Adult; Affective Symptoms; Alcoholism; Comorbidity; Depressive Disorder; Europe; Female; Humans; Levodopa; Male; Middle Aged; Opioid-Related Disorders; Predictive Value of Tests; Psychiatric Status Rating Scales; Psychometrics; Regression Analysis; Severity of Illness Index; Substance-Related Disorders | 2008 |
Levodopa dependence: a case report.
Topics: Female; Humans; Levodopa; Middle Aged; Parkinson Disease; Substance-Related Disorders | 1984 |
Parkinson's disease: long-term results of levodopa therapy.
Topics: Adult; Aged; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Substance-Related Disorders | 1982 |
Parkinsonism induced by solvent abuse.
Topics: Administration, Inhalation; Adult; Brain; Female; Humans; Levodopa; Parkinson Disease, Secondary; Solvents; Substance-Related Disorders; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1994 |
Pharmacologic management of movement disorder after midbrain haemorrhage.
Topics: Activities of Daily Living; Adult; Brain Neoplasms; Carbidopa; Cavernous Sinus; Central Nervous System Stimulants; Cerebral Hemorrhage; Dopamine Agents; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Hemangioma, Cavernous; Humans; Levodopa; Male; Mesencephalon; Methamphetamine; Movement Disorders; Substance-Related Disorders | 1998 |
Combined bupropion-levodopa-trazodone therapy of sleep-related eating and sleep disruption in two adults with chemical dependency.
Topics: Adult; Antidepressive Agents, Second-Generation; Antiparkinson Agents; Bupropion; Depressive Disorder, Major; Drug Therapy, Combination; Feeding and Eating Disorders; Female; Humans; Levodopa; Male; Substance-Related Disorders; Trazodone; Wakefulness | 2000 |
The straight dope on addiction to dopamimetic drugs.
Topics: Humans; Levodopa; Parkinson Disease; Substance-Related Disorders | 2002 |
Apomorphine revived: fortified, prolonged, and improved therapeutical effect.
Topics: Aged; Alcoholism; Apomorphine; Benserazide; Capsules; Drug Combinations; History, 18th Century; History, 20th Century; Humans; Levodopa; Male; Substance-Related Disorders; Tablets | 1978 |
Prescribing problems in the elderly.
Topics: Aged; Antidepressive Agents; Antihypertensive Agents; Digoxin; Drug Prescriptions; Female; Humans; Hypnotics and Sedatives; Levodopa; Male; Pharmaceutical Preparations; Physician's Role; Substance-Related Disorders; Tranquilizing Agents | 1978 |
Amphetamine-induced dopaminergic hypersensitivity in guinea pigs. Implications in psychosis and human movement disorders.
Topics: Amphetamine; Animals; Apomorphine; Behavior; Behavior, Animal; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Guinea Pigs; Humans; Levodopa; Movement Disorders; Psychoses, Substance-Induced; Reaction Time; Receptors, Drug; Schizophrenia; Stereotyped Behavior; Substance-Related Disorders | 1975 |
Dopaminergic responsivity during cocaine abstinence: a pilot study.
Topics: Adult; Carbidopa; Cocaine; Dopamine Agents; Drug Combinations; Growth Hormone; Homovanillic Acid; Humans; Levodopa; Male; Methoxyhydroxyphenylglycol; Middle Aged; Prolactin; Receptors, Dopamine; Substance Withdrawal Syndrome; Substance-Related Disorders | 1992 |
L-dopa abuse in a patient with former alcoholism.
Topics: Adult; Alcoholism; Humans; Levodopa; Male; Parkinson Disease, Secondary; Substance-Related Disorders | 1992 |
Subcutaneous apomorphine for parkinsonian patients with psychiatric side effects on oral treatment.
Topics: Administration, Oral; Aged; Apomorphine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Injections, Subcutaneous; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Substance-Related Disorders | 1991 |
A pilot trial of levodopa/carbidopa in early cocaine abstinence.
Topics: Adult; Arousal; Carbidopa; Cocaine; Drug Therapy, Combination; Humans; Levodopa; Pilot Projects; Substance Withdrawal Syndrome; Substance-Related Disorders | 1990 |
Quantitative urine testing. A new tool for diagnosing and treating cocaine use.
Topics: Adolescent; Adult; Amantadine; Amino Acids; Cocaine; Female; Humans; Levodopa; Male; Radioimmunoassay; Substance-Related Disorders | 1989 |
Levodopa addiction. A case study.
Topics: Adult; Dermatitis, Seborrheic; Dose-Response Relationship, Drug; Female; Humans; Levodopa; Muscle Rigidity; Paranoid Disorders; Parkinson Disease, Secondary; Psychoses, Substance-Induced; Risk Factors; Substance Withdrawal Syndrome; Substance-Related Disorders | 1988 |
Treatment of dopaminomimetic psychosis in Parkinson's disease with electroconvulsive therapy.
Topics: Aged; Electroconvulsive Therapy; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Substance-Related Disorders | 1988 |
Stepwise detoxification from cocaine. A promising regimen.
Topics: Adolescent; Adult; Amantadine; Bromocriptine; Cocaine; Desipramine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Substance Withdrawal Syndrome; Substance-Related Disorders; Tryptophan; Tyrosine | 1988 |
Clinical trial of carbidopa-L-dopa combination for cocaine abuse.
Topics: Carbidopa; Cocaine; Drug Therapy, Combination; Humans; Levodopa; Substance-Related Disorders | 1986 |
Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acute Disease; Adult; Carbidopa; Chronic Disease; Drug Combinations; Female; Humans; Levodopa; Male; Parkinson Disease; Pyridines; Substance-Related Disorders; Substantia Nigra | 1985 |
Sinemet "abusers".
Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Humans; Levodopa; Male; Middle Aged; Self Administration; Substance-Related Disorders | 1985 |
[Sleep: recent physiological acquisitions and clinical and pharmacological perspectives].
Topics: Animals; Brain; Cerebral Cortex; Electrocardiography; Electroencephalography; Electromyography; Electrooculography; Environment; Forecasting; Humans; Levodopa; Mental Disorders; Mesencephalon; Neurotransmitter Agents; Norepinephrine; Rats; Respiration; Reticular Formation; Sleep; Sleep Deprivation; Sleep Wake Disorders; Sleep, REM; Substance-Related Disorders; Telencephalon | 1974 |